Department of Chemistry, Beckman Institute for Advanced Science and Technology, The Neuroscience Program, Carle Illinois College of Medicine, University of Illinois at Urbana─Champaign, 600 S. Mathews Avenue, Urbana, Illinois 61801, United States.
Beckman Institute for Advanced Science and Technology, Department of Bioengineering, University of Illinois at Urbana─Champaign, Urbana, Illinois 61801, United States.
Inorg Chem. 2023 Dec 18;62(50):20820-20833. doi: 10.1021/acs.inorgchem.3c02929. Epub 2023 Dec 7.
The broader utilization of Cu positron emission tomography (PET) imaging agents has been hindered by the unproductive demetalation induced by bioreductants. To advance the development of Cu-based PET imaging tracers for Alzheimer's Disease (AD), there is a need for novel ligand design strategies. In this study, we developed sulfur-containing dithiapyridinophane (N2S2) bifunctional chelators (BFCs) as well as all nitrogen-based diazapyridinophane (N4) BFCs to compare their abilities to chelate Cu and target Aβ aggregates. Through spectrophotometric titrations and electrochemical measurements, we have demonstrated that the N2S2-based BFCs exhibit >10 orders of magnitude higher binding affinity toward Cu(I) compared to their N4-based counterparts, while both types of BFCs exhibit high stability constants toward Cu(II). Notably, solid state structures for both Cu(II) and Cu(I) complexes supported by the two ligand frameworks were obtained, providing molecular insights into their copper chelating abilities. Aβ binding experiments were conducted to study the structure-affinity relationship, and fluorescence microscopy imaging studies confirmed the selective labeling of the BFCs and their copper complexes. Furthermore, we investigated the potential of these ligands for the Cu-based PET imaging of AD through radiolabeling and autoradiography studies. We believe our findings provide molecular insights into the design of bifunctional Cu chelators that can effectively stabilize both Cu(II) and Cu(I) and, thus, can have significant implications for the development of Cu PET imaging as a diagnostic tool for AD.
铜正电子发射断层扫描(PET)成像剂的广泛应用受到生物还原剂诱导的非生产性脱金属作用的阻碍。为了推进用于阿尔茨海默病(AD)的基于铜的 PET 成像示踪剂的开发,需要新的配体设计策略。在这项研究中,我们开发了含硫二噻并吡啶并环(N2S2)双功能螯合剂(BFC)以及全氮二氮杂并吡啶并环(N4)BFC,以比较它们螯合铜和靶向 Aβ 聚集物的能力。通过分光光度滴定和电化学测量,我们证明基于 N2S2 的 BFC 对 Cu(I) 的结合亲和力比基于 N4 的 BFC 高 10 个数量级,而这两种 BFC 对 Cu(II) 都表现出高稳定常数。值得注意的是,获得了由两种配体骨架支撑的 Cu(II)和 Cu(I)配合物的固态结构,为它们的铜螯合能力提供了分子见解。进行了 Aβ 结合实验以研究结构-亲和力关系,荧光显微镜成像研究证实了 BFC 及其铜配合物的选择性标记。此外,我们通过放射性标记和放射自显影研究研究了这些配体在 AD 的基于 Cu 的 PET 成像中的潜在应用。我们相信我们的发现为设计双功能 Cu 螯合剂提供了分子见解,这些螯合剂可以有效地稳定 Cu(II)和 Cu(I),因此对开发 Cu PET 成像作为 AD 的诊断工具具有重要意义。